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Abstract
Background: The Wnt non-canonical pathway (Wnt5a > Frizzled-2 > cyclic GMP phosphodiesterase/Ca
2
+-mobilization pathway regulates the activation of NF-AT) is mediated by three mammalian Dishevelleds (Dvl1,
Dvl2, and Dvl3) and the role of the C-terminal region unique to Dvl3 was interrogated.
Results: Dvl1, Dvl2, and Dvl3 are expressed at varying levels in mouse totipotent F9 embryonal teratocarcinoma
cells. The expression of each endogenous Dvl isoform, as defined by knock-down with siRNA, was obligate for
Wnt5a to activate NF-AT-sensitive transcription. Elements upstream of effectors, e.g., cGMP phosphodiesterase and
Ca
2+-mobilization, were blocked by knock-down of any one of the Dvls; thus, with respect to Wnt5a activation of
NF-AT Dvls are not redundant. Among the three Dvl isoforms, the C-terminal sequence of Dvl3 is the most
divergent. Deletion of region of Dvl3 abolishes Wnt5a-stimulated signaling. Alanine (Ala)-substitution of histidine
(His) single amino acid repeats at 637,638 and/or 647,648 in Dvl3, like C-terminal deletion, abolishes Wnt 5a signal
propagation. Phenylalanine (Phe)-substitution of the same His-repeats in Dvl3 mimics Wnt5a stimulated NF-AT-
sensitive transcription.
Conclusions: The C-terminal third of Dvl3 and His single amino acid repeats 637,638 and 647,648 (which are
unique to and conserved in Dvl3) are essential for Wnt5a activation of the non-canonical pathway, but not the
Wnt3a activation of the canonical pathway.
Background
Wnt signaling is essential for normal embryonic pattern-
ing, development, cellular proliferation and homeostasis
[1-4]. Wnt ligands initiate intracellular signaling path-
ways by binding to the G-protein-coupled receptors
(GPCR), Frizzleds (Fzs) [5-9]. The Wnt-sensitive path-
ways include the canonical (Wnt/b-catenin) and the
non-canonical (planar cell polarity and Wnt/Ca
2+)p a t h -
ways [10-15]. For the canonical pathway, absent Wnt,
cellular b-catenin is subjected to proteasome mediated
degradation by the destruction complex that includes,
among other proteins, Axin and the product of the ade-
nomatous polyposis coli gene, which facilitate the phos-
phorylation of b-catenin by the Ser/Thr protein kinase
glycogen synthase kinase 3b[16-20]. This phosphoryla-
tion that occurs in the absence of Wnt3a fosters ubiqui-
tination and degradation of b-catenin [21-23]. In the
presence of Wnt, activation of Frizzled receptor leads to
inhibition of glycogen synthase kinase 3b and stabiliza-
tion of b-catenin [24-26], both of which are Dvl-depen-
dent[17,27]. Nuclear accumulation of b-catenin yields
activation of lymphoid-enhancer factor/T-cell factor
(Lef/Tcf)-sensitive transcription of developmentally-
related genes [5,28]. Post-transcriptional regulation of
b-catenin mRNA also plays a role in Wnt-stimulated
regulation of b-catenin [29].
Wnt5a, operating via Frizzled-2, leads to activation of
cyclic GMP phosphodiesterase (cGMP PDE) [30-32], a
decline in intracellular cyclic GMP, and sharp transient
increase of intracellular Ca
2 [32-35]. This Wnt5a-stimu-
lated mobilization of Ca
2+ activates the protein phospha-
tase, calcineurin, which dephosphorylates a transcription
factor, the Nuclear Factor of Activated T cells (NF-AT)
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to nuclei [36] where transcription of NF-AT-sensitive
genes is activated [34,36]. That WNT5A is a cancer-
associated gene implicated in the invasion and metasta-
sis of several human cancers, including colorectal [37],
breast and pancreas [38], heightens the need to more
fully understand the function and dysfunction of the
Wnt non-canonical pathway.
Mammalian cells express three isoforms of the phos-
phoprotein Dishevelled (Dvl) [39-42], a scaffold protein
harboring three well-known highly-conserved domains,
i.e., DIX, PDZ, and DEP [43,44]. For example, Wnt5a
has been shown to induce Dvl phosphorylation via
casein kinase 1, altering the distribution of Dvl [45]. The
DIX domain is essential for Dvl-Dvl or Dvl-Axin dimeri-
zation [17]. DIX and PDZ domains are necessary for
Wnt canonical signaling. Deletion of either DIX or PDZ
domain blocks Wnt canonical pathway [17,46,47]. The
DEP domain is essential for the PCP signaling, in tan-
dem with Daam [44,48,49]. C-terminal to the DEP
domain is the region of greatest dissimilarity among
Dvl1, Dvl2, and Dvl3. Three isoforms of Dvl appear to
function cooperatively as well as uniquely with respect
to mediation of Wnt3a-stimulated canonical signaling
[50]. Dishevelled has been implicated as mediating
Wnt5a-stimulated activation of PKC [51], but what role
mammalian Dvls play in Wnt5a-stimulated regulation of
the overall pathway to activation of NF-AT-sensitive
gene transcription is unknown. We sought to answer
the fundamental question of whether or not Dvl iso-
forms are functionally redundant with respect to the
regulation of the non-cano n i c a lp a t h w a yb yW n t .
Furthermore, we sought to interrogate the C-terminal
region of mammalian Dvls in particular, since this is the
region of these molecules that diverge most at the level
of sequence. Finally, we sought to investigate the role of
two single His-repeats found in the distal region of the
C-terminus of Dvl3. These single His-repeats are unique
t oo n l yas i n g l em e m b e ro ft h eD v lf a m i l y ,D v l 3 .W e
make use of totitpotent mouse F9 teratocarcinoma cells,
a useful model of early development [52,53] and differ-
entiation [54]; we interrogated each question, establish-
ing that the non-canonical pathway is most sensitive to
suppression of Dvl3 (althougha l lt h r e eD v l sa r en e c e s -
sary for normal signaling) and that conserved His-
repeats unique to C-terminus of Dvl3 are obligate for
non-canonical signaling of Wnt5a to the NF-AT-depen-
dent transcriptional response.
Results
Dishevelleds mediate Wnt-stimulated NF-AT activation
Totipotent mouse embryonal carcinoma F9 cells trans-
fected to express rat Frizzled-2 (Fz2) provided an opti-
mal system for the biochemical analysis of Wnt5a/Fz2
signaling [52,53]. Upon treatment with Wnt5a, F9 cells
differentiate into primitive endoderm, characteristic of
early mouse development [8]. Stimulating F9 cells with
Wnt5a provoked activation of NF-AT-sensitive tran-
scription (Figure 1A). This marked activation of NF-AT-
sensitive gene transcription was provoked in cells
expressing Frizzled-2, but not in those expressing either
Frizzled-1 (Fz1) or empty vector (EV). Mouse F9 cells
express all three isoforms of Dishevelled [50], i.e., Dvl1,
Dvl2, and Dvl3 (Figure 1B). Dapper1 acts as a negative
modulator of the canonical Wnt3a/b-catenin signaling,
antagonizing Dvl function [55], so our first test of the
role of Dvl in the non-canonical pathway was expression
by use of Dapper1. F9 cells were transiently transfected
with an expression vector harboring a Myc-tagged ver-
sion of mouse Dapper1 (verified by immunoblotting,
Figure 1B). The expression of Dapper1 clearly abolished
the ability of Wnt5a to activate NF-AT-sensitive tran-
scription. Thus, we concluded that Dishevelleds play an
essential role in mediating Wnt5a-stimulated non-cano-
nical signaling to the level of NF-AT-dependent
transcription.
Dishevelleds-1, -2, and -3 are each essential for Wnt5a
activation of the non-canonical pathway
The individual roles of each mammalian Dvl isoform in
Wnt5a-stimulated activation of NF-AT-sensitive tran-
scription were interrogated by treating cells with
Dvl-isoform-specific siRNAs. To preclude misleading
possible “off-target” effects associated with siRNA treat-
ment, we routinely employ two or more distinct siRNA
targeting sequences for every target, in this case for
each of the three mammalian Dvls. The treatment of
cell with siRNA individually suppressed Dvl1, Dvl2, and
Dvl3 (Figure 1C); each siRNA suppressed expression of
only its targeted Dvl isoform. Treatment with “control”,
scrambled siRNAs designed by the commercial supplier
were without effect (data not shown). The relative levels
of expression of each Dvl has been reported in mouse
F9, mouse P19, and human HEK cells; the rank order of
expression is Dvl2 > > > Dvl3 > Dvl1 [50]. Expression of
each Dvl isoform was knocked-down by > 80%.
Knock-down (KD) of any one of the mammalian Dvl
isoforms abolishes the ability of Wnt5a to regulate the
overall pathway to the level of NF-AT-dependent tran-
scriptional activation (Figure 1C). As noted, KD pro-
voked by an additional set of siRNAs targeting the same
isoforms yielded identical results (additional file 1).
Thus, KD of either Dvl1 alone, or of Dvl2, or of Dvl3 all
abolished activation of NF-AT-sensitive transcription in
response to Wnt5a. We conclude that Dvl isoforms do
not display frank “redundancy”.K n o c k - d o w no fe i t h e r
the most abundant Dvl isoform (i.e., Dvl2, constituting >
90% of Dvl pool) or Dvl1 (< 5% of the Dvl pool) or Dvl3
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Page 2 of 16Figure 1 Dvl1, Dvl2, and Dvl3 expression are each required for Wnt5a/Fz2/NF-AT signaling. A, mouse F9 stable clones expressing rat
Frizzled1 (Fz1), rat Frizzled2 (Fz2) or empty vector (EV) [30] were treated with vehicle (-), Wnt3a or Wnt5a for 6 hours and the activity of NF-AT-
dependent luciferase was measured. ***p < 0.001, compared with corresponding vehicle-treated group; ###, p < 0,001, compared with Wnt5a-
treated “EV” group. B, Myc-Dapper1 (Myc-Dpr) was expressed (assayed by immunoblotting, bottom panel) in F9 clones expressing Fz2. The
activity of NF-AT reporter in response to Wnt5a was determined as described. C, Suppression of Dvl1, Dvl2, or Dvl3 using siRNA targeting a
single Dvl isoform was conducted in F9 clones expressing Fz2. The activation of NF-AT-sensitive transcription in the presence (+) or absence (-)
of Wnt5a was assayed by using a luciferase reporter. **, p ≤ 0.01, compared with basal (-Wnt5a) in control group; ##, p ≤ 0,01, compared with
Wnt5a-treated (+Wnt5a) control group. Suppression of Dvl1, 2 or 3 by using siRNA was examined by immunoblotting. The blots of actin were
shown as loading controls. D, F9 cells expressing Fz2 were treated with variable amounts of siRNAs targeting a single Dvl isoform. The activation
of the NF-AT-dependent luciferase in response to Wnt5a was measured. The data are plotted as “% of maximal” of the Wnt5a-sensitive luciferase
response versus the extent of knock-down (KD) in individual Dvl isoforms produced by treatment of increasing amounts of siRNA. The level of
Knock-down for each Dvl was verified by immunoblotting (data not shown). E, Increased amounts of Dvl were expressed in F9 clones expressing
Fz2. The activation of NF-AT-sensitive transcription in the presence (left panel) or absence (right panel) of Wnt5a was assayed by using a
luciferase reporter. The luciferase activities were plotted versus the amount of immunoreactive staining for the HA-tag quantified in the blots
(data not shown).
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non-canonical pathway.
Non-canonical signaling: differential sensitivity to loss of
individual Dvls
Differential sensitivity of the canonical Wnt/b-catenin/
Lef-Tcf-dependent transcriptional pathway to loss of
individual mammalian Dvl1, Dvl2, and Dvl3 has been
shown [50]. Since KD of any one of the individual Dvl
isoforms succeeded in abolishing the overall Wnt5a-
stimulation of NF-AT-sensitive transcriptional, we
probed if this non-canonical signaling displays differen-
tial sensitivity to the level of expression of individual
Dvls. Cells were treated with sufficient amounts of
siRNAs targeting the expression of an individual Dvl
isoform to achieve varied levels of expression from
~80% to ~20%, as established by immunoblotting (data
not shown). Curves plotting Dvl expression versus
NF-AT-sensitive transcription are displayed (Figure 1D)
and were remarkable in several respects. KD of ~25% of
Dvl3 provoked about a 50% reduction in Wnt5a-stimu-
lated non-canonical signaling. On the other hand, KD of
Dvl2, which constitutes > 90% of the Dvl pool, had
to reach > 65% before the overall Wnt5a-sensitive
non-canonical pathway was impacted. The effects of the
stepwise KD of Dvl1 displayed a curve intermediate
between those for KD of Dvl3 and of Dvl2 (Figure 1D).
Thus, the Wnt5a-stimulated non-canonical pathway
appears to display the same rank order for sensitivity to
graded KD of individual mammalian Dvl isoforms (Figure
1D), as was noted for Wnt3a-stimulation of the canonical
b-catenin pathway [50], i.e., Dvl3 > Dvl1 > > Dvl2.
Non-canonical signaling: differential sensitivity to
overexpression of Dvls
Transient expression of Dishevelleds has been shown to
activate the Wnt canonical pathway in the absence of
Wnt3a [50]. We sought to interrogate if overexpression
of individual Dvl isoforms might impact the ability of
Wnt5a-stimulated pathway to operate in either the pre-
sence or absence of Wnt5a. Overexpression of Dvl1, or
Dvl2, or Dvl3 was found to activate the non-canonical
pathway (Figure 1E). The effect of overexpression of
each Dvl isoform on the response was bell-shaped. Gen-
erally, activation of the non-canonical pathway increased
with increasing expression of any one of the mammalian
Dvl isoforms. When the Wnt5a-stimulated response was
the output, the effects of overexpression of any one Dvl
peaked at ~2.75-fold over basal. There above, increased
expression of each isoform uniformly attenuated the
response. The rank order (from most to least effective)
for the ability of a Dvl to potentiate the Wnt5a-stimu-
lated NF-AT-sensitive transcriptional response was Dvl3
> Dvl1 > Dvl2. This same rank order was displayed for
the response to increased expression of Dvl isoform
alone, in the absence of Wnt (- Wnt5a). Dvl3 appears to
be most intimately involved in the Wnt5a-stimulated
non-canonical response. The NF-AT response is most
sensitive to decreases in Dvl3 that attenuate the non-
canonical pathway as well as to overexpression of Dvl3
that potentiate the response to Wnt5a.
Dvls impact the Wnt non-canonical pathway upstream of
cGMP and intracellular Ca
2+mobilization
We sought to discern the position at which mammalian
Dvls acted in the Wnt5a-stimulated non-canonical path-
way. The overall non-canonical pathway from Wnt5a
treatment to activation of NF-AT-dependent transcrip-
tion was blocked by Dapper1 as well as by KD of Dvl1,
Dvl2, or Dvl3 (Figure 1). The ability of KD of individual
Dvl isoforms to influence signals downstream of hetero-
trimeric G-proteins [53] was interrogated at the level
of the G-protein effector, cGMP phosphodiesterase
(Figure 2A). In cells expressing endogenous levels of
each mammalian Dvl, Wnt5a activated cyclic GMP
phosphodiesterase provokes a sharp decline in intracel-
lular cyclic GMP (cGMP). The siRNA-induced KD of
each Dvl individually abolished the ability of Wnt5a to
activate cGMP phosphodiesterase, as read-out by the
degradation of intracellular cGMP (Figure 2A). The
response to Wnt5a in Dvl isoform-deficient cells was
probed downstream, at the level of Ca
2+ mobilization
[34,56]. Ca
2+ mobilization was activated by Wnt5a in
the control mouse F9 cells (Figure 2B). The KD of indi-
vidual Dvls abolished the ability of Wnt5a to provoke
the Ca
2+-mobilization. Thus, Dvl1, Dvl2, and Dvl3
appear to be modulating the Wnt5a non-canonical
signaling upstream of cGMP phosphodiesterase, a well
known G-protein effector, mediating Wnt5a effects.
Co-localization of Dvls
Dvls share high homology in primary sequence, i.e., the
overall identity of Dvl1 to Dvl2 is 63.6%; the overall
identity of Dvl3 to Dvl2 is 71.5%. Each Dvl also dis-
plays a common set of motifs, including DIX, PDZ and
DEP domains. The localization of Dvl2 and Dvl3 was
interrogated by immunohistochemical methods using
AlexaFluor488-conjugated secondary antibody to stain
Dvl2 (green) and AlexaFluor595-conjugated secondary
antibody to stain Dvl3 (red, Figure 3A). Labeling pat-
terns for both Dvl2 (panel a)a n dD v l 3( p a n e lb)a r e
punctate, localized throughout the cytoplasm (Figure
3A). These patterns indeed are similar to those
reported earlier in studies of Dvl2 alone [40,57]. By
merging images, we established that the bulk of either
Dvl2 or Dvl3 is not co-localized (panels c, d). For the
highly abundant Dvl2, co-localization of < 20% with
Dvl3 would not have been unexpected. The presence
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cells) not co-localized with the ~18-fold more abun-
dant Dvl2 in these cells was not anticipated and was
therefore of great interest. We next extended these
efforts at interrogating the extent of Dvl co-localization
(of Dvl2 and Dvl3) to cells made deficient of a single
Dvl isoform (Figure 3B). In cells made deficient of any
one Dvl, co-localization of Dv2 with Dvl3 was appar-
ent, but again only partial (see panel “merge”). Remark-
ably, there was no major change in punctate patterns
observed immunohistochemically in the distribution/
localization of Dvl2 or Dvl3 in cells made deficient of
another Dvl (Dvl1) by siRNA treatment. The KD of
Dvl1 had no effect on the expression, localization, and
co-localization of Dvl2 and Dvl3. Patterns of either
Dvl2 or Dvl3 as well as their co-localization (“merge”
panels) were similarly seemingly unaffected by Wnt5a
(Figure 3C).
As a second approach with which to probe co-locali-
zation of Dvl isoforms, immuneprecipitation (IP) of Dvls
were employed in pull-downs from lysates prepared
from untreated and Wnt5a-treated cells. The analysis
was conducted with IPs of Dvl2 and of Dvl3 (anti-Dvl1
antibodies were unable to affect a quantitative pull-
down of their targets from cell lysates). IPs and superna-
tants of samples of cell lysates probed following the
immuneprecipitation were subjected to sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and then immunoblotting (IB). These biochemical
results confirm the results obtained from immunohisto-
chemical co-localization studies, i.e.D v l 2a n dD v l 3
clearly do associate (left panels of Figure 3D, E). How-
ever, less than 10% of each Dvl is found in association
with the other Dvl under these conditions of immuno-
precipitation. Treating the cells with Wnt5a yielded no
detectable differences of Dvl content in the analysis of
fractions both pre- and post-IP (right panel of Figure
3D, E). Thus, such partial co-localization of Dvl iso-
forms would not seem a likely explanation by which to
rationalize the essential character of each Dvl isoform
regarding its function in Wnt5a-stimulated non-canoni-
cal signaling.
Figure 2 Dvl3 is requisite in Wnt5a/Fz2/cGMP/Ca
2+signaling. A, Fz2 expressing cells were treated with control siRNA (-) or siRNA targeting
individual Dvl isoforms. Cells were treated with vehicle (-Wnt5a), or Wnt5a (+Wnt5a) for 45 min and cellular cGMP was assayed (left panel).
Suppression of Dvl1, 2 or 3 by using siRNA was examined by immunoblotting (right panel). B, cells were treated for 48 hr with either control
siRNA (Ctr) or siRNA targeting individual Dvl isoforms. After loaded with Fura2, cells were challenged by Wnt5a (+Wnt5a). A representative graph
of Ca
2+ transient presented as A340/A380 for cells treated with different siRNA presented. Each line depicts the mean values obtained from 20
cells selected randomly.
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Figure 3 Dvl2 and Dvl3 form punctate complexes. A, Fz2 expressing cells were cultured on a cover-glass in a MatTak culture dish. Cells were
fixed and Dvl2 and Dvl3 were doubly stained by using antibodies against Dvl2 or Dvl3. B, cells were treated with siRNA targeting individual Dvl
isoforms for 2 days and cultured on a cover-glass in a MatTak culture dish. Cells were fixed and Dvl2 and Dvl3 were doubly stained by using
antibodies against Dvl2 or Dvl3. C, cells were treated with Wnt5a for indicated time periods. Cells were fixed and cellular Dvl2 and Dvl3 were
doubly stained by using specific antibodies against Dvl2 or Dvl3, respectively. D and E, cells were treated with Wnt5a for indicated time periods.
Immunoprecipitation-based “pull-downs” from whole-cell lysates were performed by using specific antibodies that either recognizes only Dvl3
(panel D), or recognizes only Dvl2 (panel E). The Dvl-based complexes isolated in the pull-downs ("IP:Dvl3” and “IP:Dvl2"; left panels in D and E,
respectively), whole-cell lysates ("Total"; right panel), as well as supernatant fraction following the immune precipitation ("post-IP of Dvl3” and
“post-IP of Dvl2"; right panels in D and E, respectively) were subjected to SDS-PAGE and the resolved proteins transferred to nitrocellulose blots.
The blots were stained with antibodies specific for each Dvl isoform. A set of representative images of immunoblotting are shown.
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The degree of homology that exists among mammalian
Dvl1-3 fostered our study of whether or not overexpres-
sion of one isoform might possibly “rescue” the absence
of Wnt5a-stumulated NF-AT-dependent transcription in
the Dvl3-deficient cells. Is it possible to overcome the
a b s e n c eo fD v l 3t h a tc o n s t i t u t e s<5 %o fp o o lt h r o u g h
overexpression of the remaining two isoforms? Cells
were made Dvl3-difficient by siRNA treatment. Dvl3-
deficiency abolished Wnt5a-stimulated NF-AT-sensitive
transcription (Figure 4A, C), as shown before (Figure 1).
Loss of endogenous Dvl3 expression showed no detect-
able influence on the expression level of the Dv2. A
slight increase in Dvl1 expression was observed,
although non-canonical signaling remained abolished.
We transiently transfected the Dvl3-deficient F9 cells
with an expression vector harboring eGFP-tagged
human Dvl3 (hDvl-eGFP). Expression of hDvl3 at the
level that was compatible with that of endogenous Dvl3
expressed in non-siRNA treated cells fully rescues the
function of the non-canonical signaling (Figure 4A, B).
Using this same Dvl3-depletion and rescue strategy, we
ascertained if expression of either Dvl1 or Dvl2 also
would rescue NF-AT-dependent transcriptional activa-
tion in Dvl3-deficient cells (Figure 4C, D). Neither Dvl1
nor Dvl2 was able to rescue non-canonical signaling in
response to Wnt5a, although expressed to levels equal
to or greater than those achieved by hDvl3-eGFP, which
fully rescued the NF-AT-dependent transcription in
response to Wnt5a. Only expression of hDvl3 rescues
non-canonical signaling in response to Wnt5a in cells
made deficient in the endogenous Dvl3, i.e., Dvl3 func-
tion is not redundant with either Dvl2 or Dvl1.
DIX domain and distal C-terminal region of Dvl3 is
essential for Wnt5a-stimulated non-canonical signaling
Using the same “rescue” strategy with Dvl3-deificient
cells, we tested the ability of Dvl3 deletion mutants to
mediate the Wnt5a-stimulated non-canonical signaling.
Sequence homology among the three mammalian Dvls
is greatest in the N-terminal region extending to
approximately reside 500, and includes three well-
known domains, i.e., DIX, PDZ, and DEP [43,44]. Dvl
sequence C-terminal to the DEP domain displays the
least homology among Dvls. We constructed mutants of
Dvl3 with deletions of the DIX, the PDZ, the DEP
domains or of the C-terminal third of the molecule (Fig-
ure 5A). Since these various domains participate in
other Wnt signaling pathways, we employed activation
of the non-canonical pathway via the b2-adrenergic
receptor/rat Frizzled2 chimera (Figure 5B) [8,30,34]. We
tested if the deletion mutants could “rescue” the acti-
vated non-canonical pathway to the level of NF-AT-
dependent transcription in Dvl3-deficient F9 cells.
Expression of the wild-type human Dvl3 fully rescued
the non-canonical signaling pathway. The loss of the
PDZ domain was without effect on the signaling, while
the deletion of the DIX domain nearly abolished the
ability of the mutant to rescue the response in Dvl3-
deficient cells. Expression of the mutant Dvl3 lacking
the DEP domain only partially rescued the non-canoni-
cal signaling. Human Dvl3 lacking the C-terminal 497-
716 region (hDvl3ΔC) abolished the ability to rescue the
non-canonical signaling pathway in Dvl3-deficient cells
(Figure 5C). Expression of full-length hDvl3, but not the
hDvl3ΔDIX nor the C-terminal truncated mutant
(hDvl3ΔC), was able to fully rescue the Wnt5a-stimu-
lated NF-AT response. Thus, although the hDvl3ΔC
mutant harbors DIX, PDZ, and DEP domains as well as
70% of the wild-type sequence, it cannot rescue non-
canonical signaling to the level of NF-AT-dependent
transcription in the mDvl3-deficient cells.
Expression of hDvl3-CT blocks the NF-AT activation
response to Wnt5a
As a second strategy with which to interrogate the func-
tional role of the C-terminal domain of Dvl3 in Wnt5a-
stimulated non-canonical signaling, we probed if the
same C-terminal region, expressed as a peptide in F9
cells, might display some effect on the signaling path-
way. We created an expression vector harboring the
hDvl3 C-terminal region (amino acid 497-716, hDvl3-
CT), expressed the peptide in F9 cells, and probed
Wnt5a-stimulated NF-AT activation (Figure 5D).
Expression of hDvl3-CT fragment, even at the lowest
amount of input DNA tested (i.e., 0.02 μg/well), actively
suppressed Wnt5a-stimulated NF-AT-sensitive tran-
scription. Increasing the expression of the hDvl3-CT
fragment provoked even greater attenuation of the
Wnt5a-stimulated NF-AT response. At 0.1 μgi n p u t
DNA/well, the hDvl3-CT fragment not only reduced the
Wnt5a-stimulated response to basal levels, but also
demonstrated the capacity to suppress the ambient NF-
AT-dependent transcription, measured in the absence of
Wnt5a. The ability of the expression of the Dvl3-CT
fragment to suppress Wnt5a-activation of the non-cano-
nical signaling suggests a dominant-interfering charac-
ter. Thus the C-terminus of Dvl3 is essential for its role
in mediating the Wnt5a stimulation of NF-AT-depen-
dent transcription.
Deletion of His single amino acid repeats (residues 630-
650) abolishes Dvl3 function in Wnt/NF-AT non- canonical
signaling
In an effort to further uncover the nature of the Dvl3
C-terminal involved in NF-AT activation in response to
Wnt5a, we compared the sequences of the C-terminal
region of all three mammalian Dvls (Figure 6A).
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ogy within approximately 2/3rds of the C-terminal
region. Of particular interest to us was the uniqueness
of single amino acid His-His repeats at two positions
(His 637, 638 and His 647, 648) of the C-terminus of
Dvl3 among mammalian Dvl3. These two His single
amino acid repeats in Dvl3 are highly conserved from
Xenopus to human (Figure 6B). Only at the level of the
fly (Drosophila, which displays only the single Dishev-
elled) is the His repeat apparently absent. Employing the
Figure 4 Expression of hDvl3, but neither hDvl1 nor hDvl2, rescues Wnt5a-stimulated NF-AT-sensitive transcriptional activation in
Dvl3-depleted cells. F9 cells stably expressing Fz2 were treated with siRNA targeting Dvl3. Dvl3-depleted cells were transfected with various
amounts of expression plasmid harboring hDvl3-eGFP (A and B), or hDvl1-eGFP or hDvl2-eGFP (C and D). The Wnt5a-sensitive transcriptional
activation was performed by the assay of NF-AT-dependent luciferase reporter (A and C). ***, p ≤ 0.001, compared with basal (-Wnt5a) in control
(-siRNA, -plasmid) group;
##, p ≤ 0.01,
###p ≤ 0.001, compared with (+Wnt5a) in control group. The cell lysates from the same batch used in
reporter assay were subjected to SDS-PAGE and the resolved proteins transferred to nitrocellulose blots. The blots were stained with antibodies
indicated (B and D). A set of representative images of immunoblotting are shown.
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Page 8 of 16Figure 5 The DIX domain and C-terminal region of Dvl3 are obligate for non-canonical signaling. A, a schematic of deletion mutants of
human Dvl3. B, F9 cells expressing b2AR/Fz2 were made deficient in Dvl3 by treating cells with siRNA targeting Dvl3. Myc-tagged hDvl3 or
mutants (i.e. hDvl3ΔDIX, hDvl3ΔPDZ, hDvl3ΔDEP) were then expressed in these cells and NF-AT-dependent reporter activity induced by activation
of the pathway (+Iso, 10 μM) was measured and displayed as “fold-activation”, setting reporter activity in control cells (-siRNA, EV) as “1” (upper
panel). **, p ≤ 0.01, ***, p ≤ 0.001 compared with basal (-Iso) in control (-siRNA, EV) group;
## p, ≤ 0.01,
###p ≤ 0.001, compared with stimulation
(+Iso) in control group. Expression of hDvl3 or mutants was analyzed by immunoblotting (bottom panel). The blots of b-actin were shown as
loading controls. C, F9 cells expressing Fz2 were treated with or without siRNA targeting Dvl3. Twenty four hours after siRNA treatment, cells
were transfected with expression vector harboring either HA-hDvl3 or HA-hDvl3ΔC. Wnt5a-stimulated NF-AT reporter activity was measured
(upper panel). **, p ≤ 0.01, compared with basal (-Wnt5a) in control (-siRNA) group;
##, p ≤ 0.01, compared with (+Wnt5a) in control group. Cell
lysates were subjected to SDS-PAGE followed by immunoblotting (IB). Results from enhanced chemical luminescence (ECL) of the exposed blots
are displayed (bottom panel). D, Various amounts of HA-tagged hDvl3-CT were expressed in F9 cells expressing Fz2. The activity of NF-AT
luciferase reporter in response to Wnt5a was assayed (upper panel). *, p ≤ 0.05, **, p ≤ 0.01, compared with basal (-Wnt5a) in control group;
#,
p ≤ 0.05,
##, p ≤ 0.01,
###p ≤ 0.001, compared with Wnt5a-treated control group. Expressions of Dvl3-CT as well as endogenous Dvl3 in cell
lysates were analyzed by immunoblotting (bottom panel).
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Page 9 of 16Figure 6 Single His-repeats at 637,638 and 647,648 are essential for Dvl3 function in Wnt5a/cGMP/Ca
2+ non-canonical signaling to
NF-AT-dependent transcription. A, sequence alignment of C-terminus of mouse Dvl1, 2, and 3 is displayed. Sequences that are common to at
least two mDvls are shaded in gray. Unique sequences of mDvl3 are highlighted in yellow. His residues located within amino acid 631-650 of
mDvl3 are displayed in red. B, Sequence alignment of mouse Dvl3 (631-650) with corresponding region of Dvl from fly Dsh, frog Dvl3 and
mammalian Dvl3 is displayed. Common sequences are shaded in gray. HH637, 638 and HH647, 678 of mouse Dvl3 and corresponding single
His-repeats of Dvl3 in other species are displayed in red. Other His residues in the region are displayed in blue. C, F9 cells stably expressing Fz2
were treated with siRNA targeting Dvl3 (siRNA). Dvl3-depleted cells were transfected with an empty vector (EV) or expression vector harboring
either Myc-hDvl3, or one of hDvl3 mutants as indicated. Activity of NF-AT-reporter was measured in response to Wnt5a (upper panel). ***, p ≤
0.001, compared with basal (-Wnt5a) in control (-siRNA and EV) group;
##, p ≤ 0.01, compared with (+Wnt5a) in control group. Expressions of
Myc-hDvl3 or mutants were analyzed by immunoblotting by using anti-Dvl3 and anti-Myc antibodies (bottom panel). D, F9 cells stably
expressing Fz1 were treated with siRNA targeting Dvl3 (siRNA). Rescue experiments were conducted by expression of either Myc-hDvl3, or Myc-
hDvl3Δ(631-650) in Dvl3-depleted cells, followed by challenging cells with or without Wnt3a. Activity of Lef/Tcf-dependent transcription was
measured by using a luciferase reporter (left panel). ***, p ≤ 0.001, compared with basal (-Wnt3a) in control (-siRNA and EV) group;
###, p ≤ 0.001,
compared with (+Wnt3a) in control group. Expressions of Myc-hDvl3 or Myc-hDvl3Δ(631-650) were analyzed by immunoblotting (right panel). E,
F9 cells expressing b2AR/Fz2 were treated with siRNA targeting Dvl3 (siRNA). Rescue experiments were conducted by expression of Myc-hDvl3
(FL), or one of Myc-hDvl3 mutants indicated, followed by activating the non-canonical pathway by treating cells with or without isoproterenol
(Iso). Activity of NF-AT-reporter was measured and analyzed (upper panel). **, p ≤ 0.01, ***, p ≤ 0.001, compared with basal (-Iso) in control
(-siRNA and EV) group;
##, p ≤ 0.01,
###, p ≤ 0.001, compared with (+Iso) in control group. The expression of each hDvl3 variant was evaluated by
immunoblotting by using anti-Dvl3 and anti-Myc antibodies. The same blots were stained with anti-b-actin antibody (IB: actin) to establish
loading equivalence. F, Dvl3-CT, Dvl3-CTΔ(631-650), Dvl3-CT HH637,8AA, or Dvl3-CT HH647,8AA was expressed in F9 clones stably expressing Fz2.
The activity of NF-AT-dependent luciferase reporter was measured following stimulation of Wnt5a (upper panel). **p ≤ 0.01, compared with basal
(-Wnt5a) in control (EV) group;
##, ≤ 0.01, compared with (+Wnt5a) in control group. Expression of Dvl3-CT or mutants at a similar level was
shown by immunoblotting (bottom panel). The blots of b-actin are shown as loading controls.
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Page 10 of 16KD-rescue strategy, we showed that the integrity of the
C-terminus (residue 631-650 containing His tandem
repeats) was essential for Dvl3 to mediate Wnt5a-stimu-
lated non-canonical signaling to NF-AT-dependent tran-
scription (Figure 5C). We extended this observation
further and tested if this same region, unique to Dvl3
and essential to non-canonical signaling, functioned
similarly in the Wnt3a-stimulated canonical b-catenin
and Lef/Tcf-dependent transcriptional response. The
Dvl3 (Δ 631-650) mutant was expressed in Dvl3-defi-
cient cells, and the Lef/Tcf-dependent transcription sen-
sitive to Wnt3a analyzed (Figure 6D). The (Δ 631-650)
mutant, not capable of rescuing the non-canonical path-
way, fully rescued the Wnt3a-stimulated canonical path-
way. Thus not only do we show that Dvl3 has a
character that can be differentiated from Dvl1 and Dvl2,
but also that the C-terminal region unique to Dvl3 is
essential for non-canonical signaling but dispensable for
canonical signaling.
Mutagenesis of His tandem repeats either 637,638 or His
647,648 abolishes Dvl3 function
We sought then to focus on specific mutation of the
single His-repeats conserved uniquely in the distal
region of the Dvl3 (Figure 6A, B). Alanine-substitution
of either His-repeat (637,638 or 647,648) abolished the
ability of the Dvl3 mutants to rescue the activation of
the non-canonical pathway (Figure 6C, E). Alanine-sub-
stitution of either His residue within the single His-
repeat (637,638) likewise abolished the ability of the
Dvl3 mutant to function in the non-canonical signaling
to NF-AT-dependent transcription (Figure 6E, Table 1).
We exhaustively interrogated His residues in the target
region of 631-650 of Dvl3 sequence by alanine-substitu-
tion (Figure 6E and Table 1). Whereas mutagenesis of
the single His-repeats essentially abolished Dvl3 function
in the non-canonical pathway, alanine substitution of
His residues elsewhere either only attenuated Dvl3
function (i.e. His 632, His 650), or had no significant
functional outcome at all (His 634). The functional
character of the alanine mutant at 637 was restored to
normal if the mutation was reversed or the alanine was
substituted with the more bulky phenylalanine substitu-
tion (Figure 6E).
Finally, we further probed the observations obtained
from alanine-substitution mutagenesis that reveals the
single His-repeats at 637,638 and at 647,648 to be essen-
tial for Dvl3 to function in the Wnt5a-stimulate
non-canonical signaling, making use of the ability of the
C-terminal fragment of DVl3 to act as a dominant-inter-
fering peptide to the function of the same pathway
(Figure 5D). Cells were transfected with empty vector
(EV) or with the vector harboring the hDvl3-CT
(497-716) of native sequence or hDvl3-CT with various
substitutions. Whereas expression of the hDvl3-CT
fragment sharply attenuates the signaling of the Wnt5a-
stimulated NF-AT-dependent transcriptional response,
the expression for the fragment in which residues
631-650 are deleted renders the dominant-interfering
capability nil. Alanine-substitution of single His-repeat
637,638 likewise abolishes the ability of the hDvl3-CT
to block non-canonical signaling. Similarly, the
HH647,648AA mutant form of hDvl3-CT no longer
functions as a dominant-interfering peptide with respect
to the Wnt5a-stimulated non-canonical signaling path-
way. Thus mutagenesis of His tandem repeats of either
637,638 or His 647,648 blocks dominant-interfering
character of the expressed C-terminal fragment of Dvl3.
Discussion
Although there is a myriad of molecules implicated in
Wnt3a-sensitive b-catenin/Lef-Tcf-dependent transcrip-
tional “canonical” signaling, Dishevelleds are common to
all proposed models for the operation of this fundamen-
tal pathway in development [7,15,44,52,58-62]. These
multivalent cytosolic phosphoprotein-scaffolds have
been shown to play crucial roles in not only the canoni-
cal Wnt/b-catenin pathway [44,50,58], but as well as in
planar cell polarity pathway [48,63]. Epistasis experi-
ments reveal that Dishevelleds operate downstream of
G-proteins in the fly [62] as well as in mammalian cells
[7,34,63]. Whereas in the fly only a single Dishevelled
(Dsh) is expressed, mammals express three isoforms of
Dishevelleds, termed Dvl1, Dvl2, and Dvl3. Marked dif-
ferences in native abundance distinguish the isoforms in
this group, as do differences in their relative functional
roles in enabling the “canonical” Wnt pathway [50].
Dvl3 is unique in many ways. The abundance of mam-
malian Dvl3 is very low (about 1/12-1/18 of Dvl2 or
total Dvls) in many cell types including mouse F9,
mouse P19 and human HEK[50]. Dvl3 is obligate for
not only the Wnt “canonical” pathway, but also has
Table 1 Comparison of His mutants of hDvl3 in the
ability of rescuing Wnt non-canonical signaling
hDvl3 mutants Rescue (%)
H637A 9 ± 4
H638A 9 ± 7
H647A 36 ± 8
H648A 33 ± 8
H632A 72 ± 9
H634A 91 ± 1
H650A 61 ± 8
F9 cells expressing b2AR/Fz2 were treated with siRNA targeting Dvl3 (siRNA).
Rescue experiments were conducted by expression of hDvl3, or hDvl3
mutants containing His to Ala point mutation as indicated. The non-canonical
pathway was activated by treating cells with or without isoproterenol (10 μM).
Activity of NF-AT-reporter was measured and analyzed, setting the full rescue
by hDvl3 as 100%.
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Page 11 of 16been shown to be obligate for Wnt3a-stimulated p38
MAPK activation [64]. Furthermore, over-expression of
Dvl3 itself stimulates Lef/Tcf-sensitive transcription,
mimicking the effect of Wnt3a [50]. We explore the
function of Dvl3 in the context of the Wnt5a-sensitive
“non-canonical” pathway that operates through
Frizzled2, G-proteins and their effectors (e.g. cGMP
phosphodiesterase) and Ca
2+ mobilization, ultimately to
regulate NF-AT-dependent transcription[34].
Mammalian Dvls are not functional redundant, but
rather interdependent. All three Dvls are required for
Wnt5a to stimulate non-canonical, NF-AT-sensitive
transcriptional activation. Dvl2 constitutes > 90% of the
total Dvl pool in F9 cells, whereas Dvl1 + Dvl3 sum to
< 10%. Dvls display differential functional roles in the
Wnt non-canonical pathway, similar to those reported
earlier in Wnt3a-stimulated canonical signaling to b-
catenin and Lef/Tcf-sensitive transcriptional activation
[50]. The rank order of the Dvls with respect to overall
function of the Wnt non-canonical pathway is identical
to that for the canonical pathway. Notably, the siRNA-
induced loss of Dvl3 individually, which results in a
block of Wnt5a signaling to NF-AT-sensitive transcrip-
tion, cannot be rescued by marked overexpression of
either Dvl1or Dvl2. Only Dvl3 expression can rescue
Wnt5a signaling in the Dvl3-deificient cells. Dvls iso-
forms are each obligate in canonical (i.e., Wnt3a/b-cate-
nin/Lef-Tcf-sensitive transcription) and non-canonical
(i.e., Wnt5a/Ca
2+/NF-AT-sensitive transcription) signal-
ing, but display important differences among the
isoforms.
Mammalian Dishevelleds display a significant degree
of sequence homology (> 70%). The highest homology
in primary sequence is found in the conserved DIX,
PDZ, and DEP domains; the least homology is found in
Dvl3, especially when comparing the C-terminus among
Dvls (Figure 6A). These observations focused our atten-
tion on the most unique region, the distal 200 amino
acid residues extending from approximately residue 500
to the C-terminus (residue 716) in Dvl3. Deletion of this
C-terminal region, like deletion of the DIX domain,
blocked Dvl3 function in the Wnt non-canonical path-
way. This same deleted fragment (hDvl3-CT) when
expressed in cells displayed dominant-interfering charac-
ter with respect to Wnt5a-stimulated activation of NF-
AT-sensitive transcription. As regards to the importance
of common DIX, PDZ and DEP domains of Dvl3 in
Wnt non-canonical signaling, we found that DIX
domain, like it is in canonical pathway [17,46], is essen-
tial for Dvl3 to function. On the contrary, PDZ domain,
demonstrated indispensible for Dvl in Wnt canonical
signaling [39], is non-essential for Wnt5a-sensitive non-
canonical signaling. DEP domain, essential for Wnt-
induced planar cell polarity [44,48], was found that dele-
tion of it attenuates Dvl3 function in Wnt/NF-AT non-
canonical pathway. We predict that the integrity of
these common domains will be maintained in Dvl1 and
Dvl2 for their functions in Wnt/NF-AT non-canonical
signaling.
Our last goal focused on interrogating two unique and
conserved landmarks in the Dvl3 C-terminus, namely
single His-repeats at 637,638 and at 647,648. These sin-
gle His-repeats are uniquely found in Dvl3 (not in Dvl1
and Dvl2); both C-terminal single His-repeats found in
Dvl3 are conserved from frog (Xenopus) to human
(H. sapiens), although lacking in the fly. Alanine-substi-
tution of either single His-repeat or deletion of both
simultaneously abolished the function of Dvl3. The
functional loss of Dvl3 resulting from loss or mutation
of these single His-repeats was demonstrated in two
very different read-outs: loss of the ability of the full-
length mutated hDvl3 to rescue Wnt5a-stimulated non-
canonical signaling in Dvl3-deficient cells; and, loss of
the dominant-interfering character of the hDvl3-CT
fragment with respect to Wnt5a-stimulated non-canoni-
cal signaling. Thus, we report that Dvl3 is not functional
redundant among mammalian Dvls with respect to the
Wnt non-canonical signaling of Wnt5a. We demonstrate
that overexpression of either Dvl1 or Dvl2 cannot rescue
non-canonical signaling in cells made deficient of Dvl3
specifically. The unique structure of the distal region of
Dvl3 C-terminus constitutesam a j o rb a s i sf o rt h er o l e
of Dvl3 in the non-canonical pathway and this role is
not shared for the Wnt3a-stimulated canonical pathway.
Lastly, single His-repeats 637,638 and 647,648 are both
structurally unique and functionally essential to Dvl3 in
enabling Wnt5a-stimulated non-canonical signaling.
Molecules that dock to and/or modify this short region
containing two single His-repeats are prime targets for
identification in the further interrogation of the molecu-
lar features of Wnt non-canonical signaling and the
roles of Dvls.
Conclusion
T h e s ed a t ad e m o n s t r a t et h r o ugh the use of several dis-
tinct strategies that His single amino acid repeats
637,638 and 647,648 in the distal C-terminus of Dvl3
are uniquely essential to function of the Wnt non-cano-
nical pathway (Wnt5a > Frizzled-2 > cGMP phospho-
diesterase/Ca
2+-mobilization regulating the activation of
NF-AT), yet non-essential to the function of the Wnt3a-
stimulated canonical pathway (Wnt3a > Frizzled-1/LRP6
> b-catenin accumulation regulating the activation of
Lef/Tcf-dependent transcription).
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Cell culture and transfection
Mouse F9 teratocarcinoma cells were obtained from the
ATCC collection (Manassas, VA). Cells were cultured in
Dulbecco’s modified Eagle’s medium (Cellgro, Manassas,
VA) supplemented with 15% heat-inactivated fetal
bovine serum (Hyclone, South Logan, UT) at 37°C in a
humidified atmosphere with 5%CO2. For transfection,
plasmid DNA was introduced into cells by using Lipo-
fectAMINE and PLUS Reagent (Invitrogen) as per the
manufacturer’s instruction. Clones stably transfected
with pcDNA3.1 harboring either rat Frizzled-2 (rFz2) or
a chimera receptor of b2-adrenergic receptor/rat
Frizzled-2 (b2AR/Fz2), were co-transfected with NF-AT-
sensitive luciferase reporter gene (pNF-AT-Luc, Strata-
gene), according to the manufacturer’s instruction. At
least three stable clones were selected in medium con-
taining G418 (0.4 mg/ml) and used in experiments.
Construction of plasmids
Expression vector pcDNA3.1 harboring eGFP-tagged
human Dvls (hDvl1-eGFP, or hDvl2-eGFP, or hDvl3-
eGFP) was constructed as described [50]. Plasmid harbor-
ing Dapper1 was a kind gift from Dr. Ken-Ichi Takemaru
(SUNY at Stony Brook). HA- or Myc-tagged (at N-termi-
nus) human Dvls were generated by PCR amplification
using pfu DNA polymerase, and PCR products were
inserted into pCMV-HA or pCMV-Myc vector (BD Bios-
ciences). Similar subcloning procedures were employed to
generate HA- or Myc-tagged hDvl3 mutants truncated at
the C-terminus (hDvl3ΔC ) ,a sw e l la sD v l 3C - t e r m i n a l
fragment (Dvl3-CT). To generate full-length hDvl3Δ631-
650 or Dvl3-CTΔ631-650, plasmids harboring either
hDvl3 or Dvl3-CT were amplified by PCR by using the
following primers: 5’CCGAGCTACGGTCCTCCC3’ and
5’ CTCGCTGGCCGCCGGCC3’. Human Dvl3 and Dvl3-
CT carrying point mutations were generated by using
QuickChange Site-Directed Mutagenesis Kit (Stratagene),
following the manufacturer’s instructions. The authenti-
city of all constructs was confirmed by direct DNA
sequencing.
Knock-down of mouse Dvl by small interfering RNA
(siRNA)
Cells were treated with 100 nM siRNA targeting one
specific isoform of Dvl using Lipofectamine 2000 (Invi-
trogen) for 48 hours. For rescue experiments, cells were
first treated with siRNA for 24 hours and then trans-
fected with expression vector harboring a Dvl or Dvl
mutant. Cells were cultured for additional 24-36 hours
and then challenged by Wnt5a (50 ng/ml, R&D Sys-
tems). At least two sets of siRNA targeting each isoform
o fD v lw e r eu s e dt oe n s u r et h ea v o i d a n c eo f
experimental results from the effects of off-target. Fol-
lowing siRNA pairs were used to target mouse Dvl1
(CCAGGAUAUUGGCUUGACAtt and UGUCAAGC-
CAAUAUCCUGGtt; CGUGAACAAGAUCACCUUUtt
and AAAGGUGAUCUUCACGtt), mouse Dvl2 (GGAA-
GAGAUCUCCGAUGACtt and GUCAUCGGAGAUCU-
CUUCCtt; GGGUUGUCUCCUGGCUUGUtt and ACA-
AGCCAGGAGACAACCCtt) and mouse Dvl3 (GGAA-
GAGAUCUCGGACGACtt and GUCGUCCGAGAUCU-
CUUCCtt; GGAGAAUCUGGACAAUGACtt and GUC-
AUUGUCCAGAUUCUCC).
Luciferase assay of NF-AT-sensitive transcriptional
activation
Mouse F9 cells stably co-transfected with NF-AT repor-
ter gene and expression vector harboring Fz1, or Fz2, or
b2AR/Fz2 were cultured in 12-well plates. Cells were
challenged with or without Wnt5a (50 ng/ml), Wnt3a
(20 ng/ml) or isoproterenol (Iso, 10 μM) for 6 hour.
Cells lysates were centrifuged, supernatants collected
and luciferase activity measured as described [34].
Immunoblotting
Cell lysates were subjected to SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) and the resolved proteins
were transferred onto nitrocellulose membranes. The
sources of primary antibodies are as follows. Anti-Dvl1
(3F12), anti-Dvl2 (10B5) and anti-Dvl3 (4D3): Santa
Cruz Biotechnology; anti-Myc: Sigma-Aldrich; anti-
eGFP: Clontech. Blots were washed and incubated with
peroxidase-conjugated secondary antibodies as described
[56]. The immune complexes were made visible by
enhanced chemiluminescence method.
Immunoprecipitation
Cells were lysed in a lysis buffer containing a cocktail of
protease inhibitors as described [50]. Supernatant were
collected after centrifugation (total lysates). Total lysates
were incubated with protein A/G agarose coupled with
anti-Dvl1, or -Dvl2 or -Dvl3 antibodies at 4°C and then
subjected to centrifugation. Supernatants were collected
(post-IP). Protein A/G agarose beads were washed 3
times with a buffer containing 20 mM Tris (pH8.0), 150
mM sodium chloride, 5 mM sodium ethylenediaminete-
traacetate and 1% TritonX-100. Proteins precipitated
(IP) were eluted in Laemmli’s solution by boiling. Total
lysates, post-IP and IP products were then subjected to
immunoblotting analysis, as described above.
Determination of intracellular cGMP accumulation
Intracellular cGMP concentration was determined
by using a commercial cGMP ELISA kit (Cayman Che-
mical, Ann Arbor, MI), as previously described [34].
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seeded onto 12-well plates and treated with control
siRNA or siRNA specifically targeting one isoform of
Dvl for 48 hours. Cells were stimulated with Wnt5a (50
ng/ml) for 45 min and lysed. Supernatants were col-
lected by centrifugation and cGMP determined.
Measurement of intracellular Ca
2+
Cells were cultured on collagen-coated, 35-mm glass
dishes (MatTek Corporation, Ashland, MA). The intra-
cellular Ca
2+ was determined as described previously
[34,56]. Briefly, cells were loaded with 2 μMF u r a - 2
acetoxymethyl ester (Molecular Probes, Inc.) in Krebs
buffer composed of 128 mM NaCl, 5 mM KCl, 80 mM
NaH2PO4,1 . 3m MM g S O 4,a n d1 . 3m MC a C l 2 for 40
minutes at 37°C. Excess Fura-2 was removed and cells
were excited at 340 nm and 380 nm by using Lambda
DG4 fast filter switcher. The intensity of emitted fluor-
escence monitored immediately after the administration
of Wnt5a (50 ng/ml). Results were expressed as ratios of
emission intensity excited at 340 nm over 380 nm
(A340/A380).
Indirect immunofluorescence microscopy
Mouse F9 cells stably expressing rFz2 were cultured on
coverglass-chamber slides pre-coated with collagen.
Cells were rinsed twice with an isotonic buffer and fixed
in 3% paraformaldehyde containing 0.1% Triton 100.
After incubation in the buffer containing 2% bovine
serum albumin for 20 minutes, cells were washed and
anti-Dvl2 antibody (1:1000, a kind gift from Dr. Mikhail
V. Semenov, Harvard Medical School) was added. For
double staining, cells were then incubated with anti-
Dvl3 (1:200, from R&D Systems) at 37°C for 30 minutes.
Following secondary antibodies were used: Alexa Fluor
594-conjugated donkey anti-goat IgG (1:1000) and Alexa
Fluor 488-conjugated goat anti-rabbit IgG (1:1000).
Fluorescence staining of Dvl2 and Dvl3 in cells was
recorded by using a Zeiss LSM510 META confocal
microscope in the Microscopy Imaging Center at SUNY
at Stony Brook.
Statistical analysis
All experiments were replicated at least three times.
Within each experiment, assays were conducted at least
in triplicate. Data are expressed as the means ± s.e.m.
Comparisons of data among groups were performed
with one-way analysis of variance followed by the New-
man-Keuls test. Statistical significance (p value of less
than 0.05) is denoted with an asterisk or a pound
symbol.
Additional material
Additional file 1: Dvl1, Dvl2, and Dvl3 expression are each required
for Wnt5a/Fz2/NF-AT signaling. Mouse F9 cells stably co-transfected
with pNF-AT-Luc and pcDNA3.b2AR/Fz2 were cultured in 12 well plates.
Suppression of Dvl1, Dvl2, or Dvl3 individually was conducted by using
either control siRNA or a second set of siRNA (as described in “Materials
and Methods”) targeting Dvl1, or Dvl2 or Dvl3, respectively. Suppression
of Dvl1, 2 or 3 by using siRNA was examined by immunoblotting (top
panel). The blots of actin were shown as loading controls. Cells were
treated with vehicle (-Iso), or isoproterenol (+Iso, 10 μM) for 6 hr and the
activity of NF-AT-dependent luciferase was measured (bottom panel).
Abbreviations
cGMP: cyclic GMP; DMEM: Dulbecco’s modified Eagle’s medium; Dsh: Fly
Dishevelled; Dvl1: Dishevelled-1; Dvl2: Dishevelled-2; Dvl3: Dishevelled-3; KD:
knock-down; NF-AT: Nuclear Factor of Activated-T cells; rFz: rat Frizzled
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